Clearly, it is still too premature to draw any conclusions; though, when comparing KIM-1 expression between participants who did not have any degree of nephrotoxicity and those who had, according to the CTCAE or AKIN, KIM-1 was identified as a potential biomarker of kidney damage in patients treated with cisplatin (p < 0.05, in both cases on D5). This evidence concerns the gene HAVCR1 and Nephropathy.